Literature DB >> 29169723

Protective effects of allicin on 1,3-DCP-induced lipid metabolism disorder in HepG2 cells.

Jing Lu1, Bijun Cheng1, Baochen Fang1, Zhuoqun Meng1, Yiying Zheng1, Xiaochen Tian1, Shuang Guan1.   

Abstract

Allicin (2-propene-1-sulfinothioic acid S-2-propenyl ester), with quite a good range of hepatoprotective and antineoplastic properties, is a functional substance from garlic (Allium sativum L.) The purpose of this study was to provide evidence that allicin could protect 1,3-DCP-induced lipid metabolism disorder in HepG2 cells. Allicin reduced the accumulation of triglycerides (TG) and total cholesterol (TC) in 1,3-DCP-induced HepG2 cells. Allicin significantly increased the phosphorylation of AMP-activated protein kinase (AMPK) and down-regulated the levels of sterol regulatory element binding protein-1 (SREBP-1) and sterol regulatory element binding protein-2 (SREBP-2) in 1,3-DCP-induced HepG2 cells. Additionally, allicin had obvious recovery influence on the phosphorylation level of PKA and CREB in 1,3-DCP-induced HepG2 cells. These observations indicated that allicin alleviated lipid metabolism disorder induced by 1,3-DCP in HepG2 cells by regulating AMPK-SREBPs and PKA-CREB signaling pathways.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  1,3-DCP; AMPK; Allicin; Lipid metabolism disorder; PKA

Mesh:

Substances:

Year:  2017        PMID: 29169723     DOI: 10.1016/j.biopha.2017.10.125

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  Mecanismos moleculares de los efectos benéficos de la alicina sobre la enfermedad cardiovascular.

Authors:  Abraham S Arellano-Buendía; Juan G Juárez-Rojas; Fernando E García-Arroyo; Laura G Sánchez-Lozada; Horacio Osorio-Alonso
Journal:  Arch Cardiol Mex       Date:  2022

2.  Lipomodulatory and anti-oxidative stress effects of a polyherbal formulation based on garlic and avocado seed extracts on high fat high sucrose diet fed rats.

Authors:  Boris K G Azantsa; Ntentie F Raissa; Mbong A Mary-Ann; Mafongang Amelie; Kamtchoum Alexine; Momo Cliffbrown; Chimou N Lauriane; Fonkoua Martin; Edoun E Ferdinand; Ngondi J Laure; Julius E Oben
Journal:  Metabol Open       Date:  2022-06-14

3.  Use of Network Pharmacology to Investigate the Mechanism by Which Allicin Ameliorates Lipid Metabolism Disorder in HepG2 Cells.

Authors:  Bijun Cheng; Tianjiao Li; Fenglin Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-12       Impact factor: 2.629

Review 4.  Cellular Mechanisms Underlying the Cardioprotective Role of Allicin on Cardiovascular Diseases.

Authors:  José L Sánchez-Gloria; Abraham S Arellano-Buendía; Juan G Juárez-Rojas; Fernando E García-Arroyo; Raúl Argüello-García; Fausto Sánchez-Muñoz; Laura G Sánchez-Lozada; Horacio Osorio-Alonso
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

5.  Roux-en-Y Gastric Bypass in Obese Diabetic Rats Promotes Autophagy to Improve Lipid Metabolism through mTOR/p70S6K Signaling Pathway.

Authors:  Nanxi Ma; Rui Ma; Kaixin Tang; Xuesong Li; Bing He
Journal:  J Diabetes Res       Date:  2020-03-26       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.